132 related articles for article (PubMed ID: 17656236)
1. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy.
Rais-Bahrami S; Drabick JJ; De Marzo AM; Hicks J; Ho C; Caroe AE; Argani P
Urology; 2007 Jul; 70(1):178.e3-6. PubMed ID: 17656236
[TBL] [Abstract][Full Text] [Related]
2. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R
Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097
[TBL] [Abstract][Full Text] [Related]
3. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
[TBL] [Abstract][Full Text] [Related]
4. Translocation carcinomas of the kidney after chemotherapy in childhood.
Argani P; Laé M; Ballard ET; Amin M; Manivel C; Hutchinson B; Reuter VE; Ladanyi M
J Clin Oncol; 2006 Apr; 24(10):1529-34. PubMed ID: 16575003
[TBL] [Abstract][Full Text] [Related]
5. Xp11 translocation renal cell carcinoma.
Ross H; Argani P
Pathology; 2010 Jun; 42(4):369-73. PubMed ID: 20438411
[TBL] [Abstract][Full Text] [Related]
6. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
[TBL] [Abstract][Full Text] [Related]
7. Adult-onset renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusion with smooth muscle stroma and abnormal vessels.
Kuroda N; Tamura M; Tanaka Y; Hes O; Michal M; Inoue K; Ohara M; Mizuno K; Lee GH
Pathol Int; 2009 Jul; 59(7):486-91. PubMed ID: 19563413
[TBL] [Abstract][Full Text] [Related]
8. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
[TBL] [Abstract][Full Text] [Related]
9. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
Koie T; Yoneyama T; Hashimoto Y; Kamimura N; Kusumi T; Kijima H; Ohyama C
Int J Urol; 2009 Mar; 16(3):333-5. PubMed ID: 19298350
[TBL] [Abstract][Full Text] [Related]
10. [A case of xp11.2 translocation renal cell carcinoma].
Horie K; Kikuchi M; Miwa K; Minamidate Y; Yokoi S; Nakano M; Deguchi T; Ehara H; Asano N; Hirose Y
Hinyokika Kiyo; 2011 Mar; 57(3):129-33. PubMed ID: 21586884
[TBL] [Abstract][Full Text] [Related]
11. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family.
Ramphal R; Pappo A; Zielenska M; Grant R; Ngan BY
Am J Clin Pathol; 2006 Sep; 126(3):349-64. PubMed ID: 16880148
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
[TBL] [Abstract][Full Text] [Related]
13. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.
Komai Y; Fujiwara M; Fujii Y; Mukai H; Yonese J; Kawakami S; Yamamoto S; Migita T; Ishikawa Y; Kurata M; Nakamura T; Fukui I
Clin Cancer Res; 2009 Feb; 15(4):1170-6. PubMed ID: 19228722
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation-associated and unusual clear cell subtypes.
Wu A; Kunju LP; Cheng L; Shah RB
Histopathology; 2008 Nov; 53(5):533-44. PubMed ID: 18983462
[TBL] [Abstract][Full Text] [Related]
15. Xp11.2 translocation renal carcinoma with placental metastasis: a case report.
Bovio IM; Allan RW; Oliai BR; Hampton T; Rush DS
Int J Surg Pathol; 2011 Feb; 19(1):80-3. PubMed ID: 19164407
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: radiological findings mimicking papillary subtype.
Kato H; Kanematsu M; Yokoi S; Miwa K; Horie K; Deguchi T; Hirose Y
J Magn Reson Imaging; 2011 Jan; 33(1):217-20. PubMed ID: 21182142
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma associated with Xp11.2 translocations, report of a case.
Jing H; Tai Y; Xu D; Yang F; Geng M
Urology; 2010 Jul; 76(1):156-8. PubMed ID: 19854481
[TBL] [Abstract][Full Text] [Related]
18. [Research advances in Xp11.2 translocation renal cell carcinoma].
Huang JH; Zhou FJ
Ai Zheng; 2008 Sep; 27(9):1006-8. PubMed ID: 18799045
[TBL] [Abstract][Full Text] [Related]
19. Pediatric renal cell carcinoma.
Sausville JE; Hernandez DJ; Argani P; Gearhart JP
J Pediatr Urol; 2009 Aug; 5(4):308-14. PubMed ID: 19443274
[TBL] [Abstract][Full Text] [Related]
20. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults.
Meyer PN; Clark JI; Flanigan RC; Picken MM
Am J Clin Pathol; 2007 Jul; 128(1):70-9. PubMed ID: 17580272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]